Literature DB >> 20153190

Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41.

Guangyan Zhou1, Dong Wu, Evan Hermel, Edina Balogh, Miriam Gochin.   

Abstract

A series of indole ring containing compounds were designed based on the structure of the gp41 complex in the region of the hydrophobic pocket. These compounds were synthesized using a Suzuki Coupling reaction, and evaluated using a fluorescence binding assay and cell-cell fusion assay. The observed inhibition constant of compound 7 was 2.1microM, and the IC(50) for cell-cell fusion inhibition was 1.1microM. Assay data indicated that 7 is a promising lead compound for optimization into an effective low molecular weight fusion inhibitor. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153190      PMCID: PMC2833348          DOI: 10.1016/j.bmcl.2010.01.111

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  24 in total

Review 1.  HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds.

Authors:  Shuwen Liu; Shuguang Wu; Shibo Jiang
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

2.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

Authors:  Gary Frey; Sophia Rits-Volloch; X-Q Zhang; Robert T Schooley; Bing Chen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

3.  A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.

Authors:  Lifeng Cai; Miriam Gochin
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

Review 4.  Electrostatics calculations: latest methodological advances.

Authors:  Patrice Koehl
Journal:  Curr Opin Struct Biol       Date:  2006-03-15       Impact factor: 6.809

5.  Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41.

Authors:  Kun Liu; Hong Lu; Ling Hou; Zhi Qi; Cátia Teixeira; Florent Barbault; Bo-Tao Fan; Shuwen Liu; Shibo Jiang; Lan Xie
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

6.  Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.

Authors:  Shuwen Liu; Hong Lu; Jinkui Niu; Yujia Xu; Shuguang Wu; Shibo Jiang
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

7.  Demonstrating the C-terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition.

Authors:  Yael Wexler-Cohen; Yechiel Shai
Journal:  FASEB J       Date:  2007-06-15       Impact factor: 5.191

8.  The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.

Authors:  Miriam Gochin; Lifeng Cai
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

Review 9.  Peptides in the treatment of AIDS.

Authors:  Fred Naider; Jacob Anglister
Journal:  Curr Opin Struct Biol       Date:  2009-07-23       Impact factor: 6.809

10.  NMR second site screening for structure determination of ligands bound in the hydrophobic pocket of HIV-1 gp41.

Authors:  Edina Balogh; Dong Wu; Guangyan Zhou; Miriam Gochin
Journal:  J Am Chem Soc       Date:  2009-03-04       Impact factor: 15.419

View more
  13 in total

Review 1.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

2.  Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41.

Authors:  Shidong Chu; Guangyan Zhou; Miriam Gochin
Journal:  Org Biomol Chem       Date:  2017-06-07       Impact factor: 3.876

3.  Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.

Authors:  Guangyan Zhou; Dong Wu; Beth Snyder; Roger G Ptak; Harmeet Kaur; Miriam Gochin
Journal:  J Med Chem       Date:  2011-10-03       Impact factor: 7.446

Review 4.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

Review 5.  Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

Authors:  Himanshu Garg; Mathias Viard; Amy Jacobs; Robert Blumenthal
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

6.  Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket.

Authors:  Miriam Gochin; Guangyan Zhou; Aaron H Phillips
Journal:  ACS Chem Biol       Date:  2011-01-07       Impact factor: 5.100

Review 7.  Small-Molecule HIV Entry Inhibitors Targeting gp120 and gp41.

Authors:  Fei Yu; Shibo Jiang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 8.  Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Authors:  Lu Lu; Fei Yu; Lifeng Cai; Asim K Debnath; Shibo Jiang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

9.  Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching.

Authors:  Shidong Chu; Miriam Gochin
Journal:  Bioorg Med Chem Lett       Date:  2013-07-22       Impact factor: 2.823

Review 10.  Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Authors:  Fei Yu; Lu Lu; Lanying Du; Xiaojie Zhu; Asim K Debnath; Shibo Jiang
Journal:  Viruses       Date:  2013-01-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.